RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of INCY
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Incyte Corporation stock price ended at $57.12 on Wednesday, after gaining 1.01%.
(Updated on Mar 27, 2024)

Sell candidate since Mar 26, 2024 Gain 1.01% PDF

The Incyte Corporation stock price gained 1.01% on the last trading day (Wednesday, 27th Mar 2024), rising from $56.55 to $57.12. During the last trading day the stock fluctuated 1.42% from a day low at $56.50 to a day high of $57.30. The price has fallen in 7 of the last 10 days and is down by -3.05% for this period. Volume fell on the last day by -146 thousand shares and in total, 1 million shares were bought and sold for approximately $83.62 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the lower of a falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $56.45 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -9.50% during the next 3 months and, with a 90% probability hold a price between $51.08 and $54.88 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

INCY Signals & Forecast

A buy signal was issued from a pivot bottom point on Tuesday, March 26, 2024, and so far it has risen 1.01%. Further rise is indicated until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Incyte Corporation stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $57.49 and $58.76. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Incyte Corporation stock

Incyte Corporation finds support from accumulated volume at $56.98 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved $0.800 between high and low, or 1.42%. For the last week the stock has had daily average volatility of 1.91%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (INCY) For The Upcoming Trading Day Of Thursday 28th

For the upcoming trading day on Thursday, 28th we expect Incyte Corporation to open at $56.97, and during the day (based on 14 day Average True Range), to move between $55.78 and $58.46, which gives a possible trading interval of +/-$1.34 (+/-2.34%) up or down from last closing price. If Incyte Corporation takes out the full calculated possible swing range there will be an estimated 4.69% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $56.98 (0.25%) than the resistance at $57.34 (0.39%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Incyte Corporation stock A Buy?

Incyte Corporation holds several negative signals and is within a falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -1.123 Sell Candidate Unchanged

Predicted Opening Price for Incyte Corporation of Thursday, March 28, 2024

Fair opening price March 28, 2024 Current price
$56.97 ( 0.257%) $57.12

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for INCY

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 57.77 1.14 %
R2 57.47 0.609 %
R1 57.28 0.278 %
Current price: 57.12
Support S1 56.67 -0.792 %
S2 56.48 -1.12 %
S3 56.17 -1.66 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 59.34 3.89 %
R2 58.37 2.19 %
R1 57.34 0.385 %
Current price 57.12
Support S1 56.98 -0.245%
S2 56.55 -1.00%
S3 0 .

FAQ

What is the symbol for Incyte Corporation Stock and on which exchange is it traded?
The symbol for Incyte Corporation is INCY and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Incyte Corporation Stock?
Incyte Corporation holds several negative signals and is within a falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Incyte Corporation Stock?
Incyte Corporation Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Incyte Corporation Stock.

What's the current price of Incyte Corporation Stock?
As of the end of day on the 2024-03-27, the price of an Incyte Corporation (INCY) share was $57.12.

What is the 52-week high and low for Incyte Corporation Stock?
The 52-week high for Incyte Corporation Stock is $76.04 and the 52-week low is $50.27.

What is the market capitalization of Incyte Corporation Stock?
As of the 2024-03-27, the market capitalization of Incyte Corporation is 12.697B.

When is the next earnings date for Incyte Corporation?
The upcoming earnings date for Incyte Corporation is May 07, 2024.
Click to get the best stock tips daily for free!

About Incyte Corporation

Incyte Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as oncogenic drivers in various liquid and solid tumor types; and ICLUSIG, a kinase inhibitor to treat chr... INCY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT